Scientists Identify New Drug Target Against Virulent Type Of Breast Cancer
Monday, August 25, 2008 - 10:35
in Health & Medicine
Researchers have identified an enzyme called Brk as a target for future drugs to fight a virulent subset of cancers overexpressing a protein called ErbB2 -- also often called HER2 -- which drives tumor cells to proliferate unchecked. Brk, they report, helps these tumors become virulent and is also implicated in the process through which the tumors develop drug resistance to "targeted" therapies Herceptin and Lapatinib.